| Nurix Therapeutics, Inc. (NRIX) |
| Q3-CY2026 | Q2-CY2026 | Q1-CY2026 | Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 |
| Balance Sheet Date | | 2026-May-31 | 2026-Feb-28 | 2025-Nov-30 | 2025-Aug-31 | 2025-May-31 | 2025-Feb-28 | 2024-Nov-30 | 2024-Aug-31 | 2024-May-31 | 2024-Feb-29 | 2023-Nov-30 | 2023-Aug-31 | 2023-May-31 | 2023-Feb-28 | 2022-Nov-30 | 2022-Aug-31 | 2022-May-31 | 2022-Feb-28 | 2021-Nov-30 | 2021-Aug-31 | 2021-May-31 | 2021-Feb-28 | 2020-Nov-30 | 2020-Aug-31 | | | | | | | | | | | | | | | | | | | | | | | | |
| Fiscal Period | | Q2-FY2026 | Q1-FY2026 | Q4-FY2025 | Q3-FY2025 | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | Q2-FY2024 | Q1-FY2024 | Q4-FY2023 | Q3-FY2023 | Q2-FY2023 | Q1-FY2023 | Q4-FY2022 | Q3-FY2022 | Q2-FY2022 | Q1-FY2022 | Q4-FY2021 | Q3-FY2021 | Q2-FY2021 | Q1-FY2021 | Q4-FY2020 | Q3-FY2020 | | | | | | | | | | | | | | | | | | | | | | | | |
| Close Price of Common Stock | 22.99$ | 24.24$ | 15.49$ | 19.04$ | 9.26$ | 11.38$ | 11.89$ | 18.85$ | 22.51$ | 20.84$ | 14.69$ | 10.34$ | 7.86$ | 9.98$ | 8.86$ | 10.97$ | 13.02$ | 12.69$ | 13.97$ | 28.95$ | 29.99$ | 26.63$ | 31.07$ | 32.86$ | 34.66$ | | | | | | | | | | | | | | | | | | | | | | | | |
| Market Cap of Common Stock | 2,385,421,984$ | 2,506,556,907$ | 1,593,038,256$ | 1,463,860,621$ | 707,538,781$ | 867,561,060$ | 901,914,820$ | 1,335,263,916$ | 1,449,911,194$ | 1,024,302,547$ | 718,254,094$ | 501,528,961$ | 378,852,558$ | 473,504,633$ | 418,839,648$ | 517,211,158$ | 612,485,213$ | 570,417,962$ | 624,986,619$ | 1,291,536,131$ | 1,332,361,411$ | 1,180,750,617$ | 1,208,847,419$ | 1,276,789,726$ | | | | | | | | | | | | | | | | | | | | | | | | | |
| QoQ% | (4.83%) | 57.34% | 8.82% | 106.90% | (18.45%) | (3.81%) | (32.45%) | (7.91%) | 41.55% | 42.61% | 43.21% | 32.38% | (19.99%) | 13.05% | (19.02%) | (15.56%) | 7.38% | (8.73%) | (51.61%) | (3.06%) | 12.84% | (2.32%) | (5.32%) | | | | | | | | | | | | | | | | | | | | | | | | | | |
| YoY% | 237.14% | 188.92% | 76.63% | 9.63% | (51.20%) | (15.30%) | 25.57% | 166.24% | 282.71% | 116.32% | 71.49% | (3.03%) | (38.15%) | (16.99%) | (32.98%) | (59.95%) | (54.03%) | (51.69%) | (48.30%) | 1.16% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Close Price of Warrant | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Close Price of Unit | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Close Price of Right | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Common Shares Outstanding | 103,781,683 | 103,701,511 | 103,399,813 | 101,807,484 | 76,872,686 | 76,433,664 | 76,234,799 | 75,870,718 | 67,083,523 | 64,356,535 | 49,136,954 | 48,718,552 | 48,503,768 | 47,631,208 | 47,444,853 | 47,172,299 | 47,147,781 | 45,040,068 | 44,853,448 | 44,664,371 | 44,556,604 | 44,403,547 | 39,119,315 | 38,864,872 | 38,845,196 | 3,792,745 | 3,667,037 | 3,595,334 | 3,521,098 | | | | | | | | | | | | | | | | | | | | |
| QoQ% | .08% | .29% | 1.56% | 32.44% | .57% | .26% | .48% | 13.10% | 4.24% | 30.97% | .86% | .44% | 1.83% | .39% | .58% | .05% | 4.68% | .42% | .42% | .24% | .35% | 13.51% | .66% | .05% | 924.20% | 3.43% | 1.99% | 2.11% | | | | | | | | | | | | | | | | | | | | | |
| YoY% | 35.01% | 35.68% | 35.63% | 34.19% | 14.59% | 18.77% | 55.15% | 55.73% | 38.31% | 35.11% | 3.57% | 3.28% | 2.88% | 5.75% | 5.78% | 5.62% | 5.82% | 1.43% | 14.66% | 14.92% | 14.70% | 1,070.75% | 966.78% | 980.98% | 1,003.21% | | | | | | | | | | | | | | | | | | | | | | | | |